Clinical trial
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction…
NCT00106392 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00106392 |
|---|---|
| Title | A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy |
| Official title | A Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Prograf (Tacrolimus, FK 506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-sparing Radical Prostatectomy |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Erectile Dysfunction, Prostate Cancer |
| Intervention type | Drug |
| Interventions | Tacrolimus, Placebo |
| Enrollment | 131 |
| Start date | Feb 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Mar 24, 2005 |
| Last update posted | Nov 23, 2010 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: